Skip Navigation

Cardiovascular Research 2003 59(2):479-487; doi:10.1016/S0008-6363(03)00433-4
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Favot, L.
Right arrow Articles by Lugnier, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Favot, L.
Right arrow Articles by Lugnier, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis

Laure Favot, Sophie Martin, Thérèse Keravis, Ramaroson Andriantsitohaina and Claire Lugnier*

Pharmacologie et Physico-Chimie des Interactions Cellulaires et Moléculaires, UMR CNRS 7034, Université Louis Pasteur de Strasbourg, 74 Route du Rhin, B.P. 24, 67401 Illkirch, France

* Corresponding author. Tel.: +33-390-244-264; fax: +33-390-244-313. claire{at}aspirine.u-strasbg.fr

Objective: Epidemiologic studies have shown that a diet rich in fruits and vegetables has a beneficial preventive effect for cancer and cardiovascular diseases. The mechanisms of these beneficial effects are not known although there is evidence that polyphenolic compounds in food may be of some benefit. The purpose of this study was to define the effect of delphinidin, a vasoactive polyphenol belonging to the class of anthocyanin, on endothelial cell proliferation and migration as well as on in vivo angiogenesis. Methods and results: Vascular endothelial growth factor-stimulated human umbilical endothelial cell migration and proliferation are potently inhibited by delphinidin. Flow cytometric analysis demonstrates that delphinidin inhibition of proliferation is correlated with the blockade of cell cycle in G0/G1 phase. Western blot analysis shows that delphinidin reverses the vascular endothelial growth factor-induced decrease in expression of cyclin-dependent kinase inhibitor p27kip1 and the vascular endothelial growth factor-induced increase of cyclin D1 and cyclin A, both being necessary to achieve the G1-to-S transition. Furthermore, delphinidin inhibits neovascularisation in vivo in chorioallantoic membrane model. Conclusion: Delphinidin overcomes in vitro and in vivo angiogenesis and thus appears promising for the development of an anti-angiogenic therapy.

KEYWORDS VEGF, vascular endothelial growth factor; bFGF, fibroblast growth factor; HUVEC, human umbilical vein endothelial cell; RWPC, red wine polyphenolic extract; cdk, cyclin dependent kinase; cki, cyclin kinase inhibitor of cyclin dependent kinase; DMSO, dimethylsulfoxide; HS, human serum; CAM, chorioallantoic membrane; L-NA, NG-L-nitroarginine; Delph, delphinidin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. Soleti, T. Benameur, C. Porro, M. A. Panaro, R. Andriantsitohaina, and M. C. Martinez
Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors
Carcinogenesis, April 1, 2009; 30(4): 580 - 588.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Baron-Menguy, A. Bocquet, A.-L. Guihot, D. Chappard, M.-J. Amiot, R. Andriantsitohaina, L. Loufrani, and D. Henrion
Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic
FASEB J, November 1, 2007; 21(13): 3511 - 3521.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Lamy, M. Blanchette, J. Michaud-Levesque, R. Lafleur, Y. Durocher, A. Moghrabi, S. Barrette, D. Gingras, and R. Beliveau
Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation
Carcinogenesis, May 1, 2006; 27(5): 989 - 996.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.